Psychedelics Controversial figure Dana Larsen gets his psychedelics business license back He had it suspended last May and his stores were raided by police in November, but it appears his perseverance has paid off Rowan DunneMarch 7, 2024
Science and Research DEA sharply increases quantities of psychedelics, cannabinoids for 2024 research Substances being produced at a more rapid rate this year will include psilocybin, DMT and delta-9 THC Rowan DunneJanuary 4, 2024
Psychedelics Terran Biosciences obtains U.S. patent approval for catalogue of novel psychedelics They include two new forms of psilocybin, orally active DMT and 5-MeO-DMT, and an ibogaine derivative Rowan DunneDecember 11, 2023
Psychedelics Vancouver police raid Medicinal Mushroom Dispensary locations, owner arrested Dana Larsen owns three shops in Vancouver that openly sell psychedelics like psilocybin mushrooms, DMT and peyote Rowan DunneNovember 3, 2023
News Antidepressants enhance DMT efficacy in patients with severe depression: Small Pharma study The study found that 100 per cent of patients were responsive and 92 per cent went into remission Natalia Buendia CalvilloSeptember 27, 2023
Psychedelics Cybin inks agreement to acquire DMT drug developer Small Pharma The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio Rowan DunneAugust 28, 2023
News PharmaTher Holdings finishes testing microneedle DMT patch The molecular structure of DMT is the backbone of some popular psychedelics being tested for medical purposes such as psilocin and LSD Natalia Buendia CalvilloJuly 19, 2023
Psychedelics UC San Diego receives US$1.5M for cognitive research on DMT Fund supporting the institution's Psychedelics and Health Research Initiative was provided by philanthropist Eugene Jhong Rowan DunneJuly 11, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
News Algernon Pharmaceuticals completes final dosing in DMT study for stroke and TBI treatment AGN Neuro plans to publish the data from the study in an upcoming issue of a peer-reviewed paper Natalia Buendia CalvilloJune 5, 2023